Frost Health LawAlabama Attorney • Pharmacist • Healthcare Executive

Compounding • Recalls • Veterinary pharmacy • Quality systems

Wedgewood Recall Calls for Veterinary Medication Inventory and Customer Checks

Wedgewood Pharmacy announced a nationwide recall of certain compounded veterinary medications on October 21 after identifying unreliable laboratory testing that could allow potency errors. The FDA-hosted notice directs pharmacies to check inventory, quarantine affected stock and notify customers who received it. Product and lot verification should guide the response. Animal owners with matching preparations should stop use, retain the medication and contact recall services.

By Toby C. “Chad” Frost • October 22, 2026
1 min read

What changed

Wedgewood’s October 21, 2026 announcement concerns selected unexpired preparations shipped nationwide from February 18 through October 6. The company identified inconsistent analytical testing data as a potential cause of strength errors.1

Pharmacies should quarantine affected stock and identify customers who received it. The notice directs animal owners to stop using matching products, retain them and contact recall services. The action concerns specified products and lots.1

Operational implications

Chad’s analysis: Treat the response as a reconciliation task. Match the product, lot and expiration against the company’s current list, document the inventory decision and confirm that downstream notices reach the right customers. Coordinate treatment changes with the veterinarian so the response also addresses continuity of care.

Source notes

  1. Wedgewood Pharmacy LLC, Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues, U.S. Food & Drug Admin., Company Announcement (Oct. 21, 2026).